Product Overview

The OraQuick® HCV Rapid Antibody Test is the FIRST and ONLY FDA-approved, point of care test for the detection of HCV antibodies. Our simple, CLIA-waived platform enables healthcare providers to deliver an accurate diagnosis in 20 minutes. The test can be completed in 3 simple steps from 5µl of fingerstick or venous whole blood with less than 2 minutes of hands on time. It is ideal for testing programs in both clinical and non-clinical settings, as well as outreach events. Examples include urgent care, labor and delivery, laboratories and physician offices

Orasure HCV

OraQuick HCV Rapid Antibody Test
The FIRST and ONLY FDA- approved, CLIA-waived test for HCV antibodies
  • >98% accuracy
  • Lab-accurate results

  • CLIA-waived with 3 simple steps
  • Requires less than 2 minutes of hands on time

  • 20 minutes from sample to result
  • Immediately link patients to care

Educational Resources